
Gayatri BioOrganics Ltd is Rated Sell by MarketsMOJO
2026-03-03 10:10:34Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 May 2025, but the analysis below reflects the stock's current position as of 03 March 2026, incorporating the latest fundamentals, returns, and financial metrics.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-02-20 10:10:34Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Gayatri BioOrganics Ltd latest results good or bad?
2026-02-10 19:21:08Gayatri BioOrganics Ltd's latest financial results indicate a troubling situation for the company. The firm has reported zero net sales for the seventh consecutive quarter, reflecting a complete operational shutdown since June 2024. In the most recent quarter, Q3 FY26, the company incurred a net loss of ₹0.22 crores, which is a marginal increase from the previous quarter's loss of ₹0.21 crores. This trend of mounting losses is compounded by a negative shareholder equity of ₹35.89 crores and a negative book value of ₹4.56 per share, highlighting severe financial distress. The data reveals that the company's operating margin remains at 0.0%, consistent with its lack of operational activity. Employee costs and interest expenses persist despite the absence of revenue, indicating ongoing financial obligations that further strain the company's resources. The accumulated losses for the nine-month period of FY2026...
Read full news article
Gayatri BioOrganics Q3 FY26: Zero Revenue, Mounting Losses Signal Operational Paralysis
2026-02-10 14:31:25Gayatri BioOrganics Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹106.00 crores, reported another quarter of complete operational shutdown in Q3 FY26 (October-December 2025), posting zero revenue and a net loss of ₹0.22 crores. The company's stock, trading at ₹14.28, remains trapped in a prolonged crisis that has seen no commercial activity for over seven consecutive quarters, raising serious questions about its viability as a going concern.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-02-09 10:10:52Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleWhen is the next results date for Gayatri BioOrganics Ltd?
2026-02-05 23:16:52The next results date for Gayatri BioOrganics Ltd is scheduled for 10 February 2026....
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-01-29 10:10:06Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gayatri BioOrganics Ltd is Rated Sell
2026-01-06 10:10:10Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Gayatri BioOrganics Ltd Hits New 52-Week High at Rs.19.99
2025-12-30 09:46:06Gayatri BioOrganics Ltd, a key player in the Commodity Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.19.99. This achievement marks a remarkable rally for the stock, reflecting strong momentum over the past year despite a slight pullback in today’s session.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
11-Feb-2026 | Source : BSENewspaper Publication for the Unaudited Financial Results for the quarter and nine months ended 31.12.2025.
Unaudited Quarterly Results For Quarter Ended 31.12.2025
10-Feb-2026 | Source : BSEUnaudited quarterly results for quarter ended 31.12.2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.02.2026
10-Feb-2026 | Source : BSEOutcome of Board meeting held on 10.02.2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






